3.00 USD
↘ 0.10 (3.23%)AT CLOSE (11:59 AM EDT)
OnKure Therapeutics, Inc. Class A Common Stock
OKURNASDAQ • USD
2.99
↘ 0.02 (0.50%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
2.99
↘ 0.02 (0.50%)
Market: CLOSED
Shares of OnKure Therapeutics, Inc. Class A Common Stock (OKUR) are trading at $2.98. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, OKUR appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Sep 14, 2026.
Open?$3.11
High?$3.14
Low?$2.98
Prev. Close?$3.10
Volume?105.2K
Avg. Volume?158.9K
VWAP?$3.05
Rel. Volume?0.66x
Bid / Ask
Bid?$2.36 × 100
Ask?$3.53 × 100
Spread?$1.17
Midpoint?$2.95
Valuation & Ratios
Market Cap?125.5M
Shares Out?40.4M
Float?24.9M
Float %?61.7%
P/E Ratio?N/A
P/B Ratio?0.73
EPS?-$1.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
Employees
45
Market Cap
125.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-10-07
Address
6707 WINCHESTER CIRCLE, SUITE 400
BOULDER, CO 80301
Phone: (720) 307-2892
BOULDER, CO 80301
Phone: (720) 307-2892
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?65
Short Sent.?53
Piotroski F-Score?0/9Weak
Altman Z-Score?8.49Safe
Confidence?36%Very Low
Short InterestHigh
Short % of Float?5.31%Elevated
Short Interest?1.3M
Days to Cover?7.7
Free Float24.9M
Avg Daily Volume171.8K
Settlement Date2026-08-31
Financial Health
Current Ratio?26.75Strong
Quick Ratio?26.75Strong
Cash Ratio?25.06Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.73CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.7CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-34.1%WEAK▾
S&P5
ROA?-32.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-47864000
Enterprise Value?$-40963442
Fundamentals ratios updated end of day